Home » Authors » James Etheridge

Articles by James Etheridge

IDM To Coordinate European Project For Cancer Vaccine

Oct. 22, 2003

By James Etheridge

Neurotech Begins Clinical Work With NT-501 Product

Oct. 15, 2003

By James Etheridge

Theraptosis Enters Collaboration With Robarts Research Institute

Oct. 15, 2003

By James Etheridge

Neurotech Begins Clinical Work With NT-501 Product

Oct. 15, 2003

By James Etheridge

Theraptosis Enters Collaboration With Robarts Research Institute

Oct. 15, 2003

By James Etheridge

French Seek To Bolster Biotech Via More Public Funding In 2004

Oct. 1, 2003

By James Etheridge

Crossroads' Conference Deals With Biotech's Ethics, Issues

Oct. 1, 2003

By James Etheridge

Seeking Funds, Flamel Files For Public Offering In U.S.

Oct. 1, 2003

By James Etheridge

Seeking Funds, Flamel Files For Public Offering In U.S.

Oct. 1, 2003

By James Etheridge

Crossroads' Conference Deals With Biotech's Ethics, Issues

Oct. 1, 2003

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...